Heron Therapeutics CEO Collard converts stock grants

Q: What HRTX shares did CEO Craig A. Collard report acquiring and delivering or withholding?

Craig A. Collard reported acquiring 50,021 common shares on October 30, 2026, and 34,788 on October 31, 2026, upon conversion of restricted stock units. He also reported 12,181 shares delivered or withheld for payment of exercise price or tax liability on October 30 and 8,471 shares on October 31.

Q: How do Craig A. Collard's HRTX restricted stock units vest?

One note says 800,337 RSUs granted January 30, 2026 vest in 16 equal quarterly installments beginning one quarter after the grant date. Another note describes 16 equal installments beginning one quarter after a January 31, 2025 grant date. Each restricted stock unit represents a contingent right to receive one common share.

Each restricted stock unit represents a contingent right to receive one share of common stock.

Available on EDGAR 11/03/2026 - 12:59 PM EST Accepted by SEC EDGAR 11/03/2026 - 12:57 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Heron Therapeutics, Inc. CEO Craig A. Collard reported conversion of restricted stock units into 50,021 common shares on October 30, 2026, and 34,788 common shares on October 31, 2026. He also reported 12,181 shares and 8,471 shares, respectively, delivered or withheld for payment of exercise price or tax liability on those dates.

Insider Trade Summary

84,809 shares exercised/converted

Exercise 6 txns

Insider Collard Craig A

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units ^F3	34,788	$0.00	$0.00
Exercise	Common Stock ^F1	34,788	--	--
Exercise Price or Tax Liability	Common Stock	8,471	$0.28	$2K
Exercise	Restricted Stock Units ^F2	50,021	$0.00	$0.00
Exercise	Common Stock ^F1	50,021	--	--
Exercise Price or Tax Liability	Common Stock	12,181	$0.28	$3K

Holdings After Transaction: Restricted Stock Units — 963,372 contracts (Direct); Common Stock — 931,086 shares (Direct)

Holdings Before and After: Restricted Stock Units, 1,048,181 to 963,372 contracts (Direct); Common Stock, 866,929 to 931,086 shares (Direct)

Footnotes (3)

F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein.
F3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Key Figures

Common shares acquired upon RSU conversion: 50,021 shares Common shares acquired upon RSU conversion: 34,788 shares Shares delivered or withheld for payment of exercise price or tax liability: 12,181 shares +3 more

6 metrics

Common shares acquired upon RSU conversion 50,021 shares October 30, 2026

Common shares acquired upon RSU conversion 34,788 shares October 31, 2026

Shares delivered or withheld for payment of exercise price or tax liability 12,181 shares October 30, 2026

Shares delivered or withheld for payment of exercise price or tax liability 8,471 shares October 31, 2026

RSUs granted 800,337 RSUs January 30, 2026 grant

Vesting installments 16 equal quarterly installments RSUs granted January 30, 2026

Key Terms

Restricted Stock Units, contingent right, time-based vesting schedule

3 terms

Restricted Stock Units technical

"Each restricted stock unit represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right technical

"a contingent right to receive one share of common stock"

time-based vesting schedule technical

"vest upon the following time-based vesting schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What HRTX shares did CEO Craig A. Collard report acquiring and delivering or withholding?

Craig A. Collard reported acquiring 50,021 common shares on October 30, 2026, and 34,788 on October 31, 2026, upon conversion of restricted stock units. He also reported 12,181 shares delivered or withheld for payment of exercise price or tax liability on October 30 and 8,471 shares on October 31.

How do Craig A. Collard's HRTX restricted stock units vest?

One note says 800,337 RSUs granted January 30, 2026 vest in 16 equal quarterly installments beginning one quarter after the grant date. Another note describes 16 equal installments beginning one quarter after a January 31, 2025 grant date. Each restricted stock unit represents a contingent right to receive one common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Collard Craig A

(Last)

(First)

(Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY

NORTH CAROLINA

27511

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/30/2026		M		50,021	A	⁽¹⁾	916,950	D
Common Stock	10/30/2026		F		12,181	D	$0.28	904,769	D
Common Stock	10/31/2026		M		34,788	A	⁽¹⁾	939,557	D
Common Stock	10/31/2026		F		8,471	D	$0.28	931,086	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	10/30/2026		M			50,021	⁽²⁾	⁽²⁾	Common Stock	50,021	$0	650,274	D
Restricted Stock Units	$0	10/31/2026		M			34,788	⁽³⁾	⁽³⁾	Common Stock	34,788	$0	313,098	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein.

3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

	/s/Kathryn Lester Attorney-in-fact for Craig Collard	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR